Nilvadipine has been demonstrated to increase blood flow to the hippocampus among people with Alzheimer’s disease, according to a recent study.
Browsing: Alzheimer’s disease
Researchers have found that the sleep history and pattern of older men and women may predict the accumulation of proteins associated with Alzheimer’s disease.
In a revolutionary approach, Cognetivity (London, UK) have created a new test for detecting dementia and Alzheimer’s disease by focusing on image cognition and the brain’s ability to analyze visual information.
In a recent study, researchers have discovered a possible link between high LDL cholesterol and early-onset Alzheimer’s disease.
Long-term antibiotic treatment may reduce the size of amyloid plaques and could alter the appearance of microglia in the brains of male mice.
In a study focused on a group of former professional athletes who have experienced multiple concussions, over half the group were reported to have higher levels of tau protein biomarkers in their cerebrospinal fluid.
Whilst at the ARUK Conference 2019, we had the pleasure of speaking with Hugh Perry about neuroinflammation and Alzheimer’s disease, particularly the role of microglia in brain homeostasis.
Researchers have identified a cause of dementia with similar symptoms to Alzheimer’s disease; this development could improve diagnosis and treatment of dementia.
Couldn’t attend the AD/PD™ 2019 Congress? Our Editor, Sharon Salt, provides her key highlights and takeaway messages from the event.
Scientists have 3D printed a transparent skull implant for mice, creating a ‘window’ to the brain for monitoring brain surface activity in real time. The implant could provide unique opportunities for research into concussions as well as Alzheimer’s and Parkinson’s diseases.